SALA, Margaux; ALLAIN, Nathalie; MOREAU, Mélanie; JABOUILLE, Arnaud; HENRIET, Elodie; ABOU-HAMMOUD, Aya; UGUEN, Arnaud; DI-TOMMASO, Sylvaine; DOURTHE, Cyril; RAYMOND, Anne-Aurélie; DUPUY, Jean-William; GERARD, Emilie; DUGOT-SENANT, Nathalie; ROUSSEAU, Benoit; MERLIO, Jean-Phillipe; PHAM-LEDART, Anne; VERGIER, Béatrice; TARTARE-DECKERT, Sophie; MOREAU, Violaine; SALTEL, Frédéric

doi:10.1038/s41388-022-02266-1

Métadonnées

Afficher la notice complète

Licence d’utilisation du document

SALA, Margaux

ALLAIN, Nathalie
BoRdeaux Institute in onCology [Inserm U1312 - BRIC]

MOREAU, Mélanie
BoRdeaux Institute in onCology [Inserm U1312 - BRIC]

Langue

Article de revue

Ce document a été publié dans

Oncogene. 2022-04-29, vol. 41, n° 18, p. 2571-2586

Résumé en anglais

Combined therapy with anti-BRAF plus anti-MEK is currently used as first-line treatment of patients with metastatic melanomas harboring the somatic BRAF V600E mutation. However, the main issue with targeted therapy is the acquisition of tumor cell resistance. In a majority of resistant melanoma cells, the resistant process consists in epithelial-to-mesenchymal transition (EMT). This process called phenotype switching makes melanoma cells more invasive. Its signature is characterized by MITF low, AXL high, and actin cytoskeleton reorganization through RhoA activation. In parallel of this phenotype switching phase, the resistant cells exhibit an anarchic cell proliferation due to hyper-activation of the MAP kinase pathway. We show that a majority of human melanoma overexpress discoidin domain receptor 2 (DDR2) after treatment. The same result was found in resistant cell lines presenting phenotype switching compared to the corresponding sensitive cell lines. We demonstrate that DDR2 inhibition induces a decrease in AXL expression and reduces stress fiber formation in resistant melanoma cell lines. In this phenotype switching context, we report that DDR2 control cell and tumor proliferation through the MAP kinase pathway in resistant cells in vitro and in vivo. Therefore, inhibition of DDR2 could be a new and promising strategy for countering this resistance mechanism.< Réduire

Métadonnées

Partager cette publication !

Licence d’utilisation du document

Discoidin Domain Receptor 2 orchestrates melanoma resistance combining phenotype switching and proliferation

Langue

Ce document a été publié dans

Résumé en anglais

URI

DOI

Unités de recherche